B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: A case-control study in Greece

Cancer Causes and Control

Volumn 21, Issue 9, 2010, Pages 1451-1459

  Dalamaga, Maria ^a   Crotty, Bradley H ^b   Fargnoli, Jessica ^b   Papadavid, Evangelia ^a   Lekka, Antigoni ^c   Triantafilli, Maria ^c   Karmaniolas, Konstantinos ^c   Migdalis, Ilias ^c   Dionyssiou Asteriou, Amalia ^a   Mantzoros, Christos S ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NIMTS HOSPITAL   (Greece)

Author keywords

Adipokine; Adiponectin; Chronic lymphocytic leukemia; Leptin; Obesity

Indexed keywords

ADIPONECTIN; LEPTIN;

AGED; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; BODY MASS; CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GREECE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADIPONECTIN; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GREECE; HUMANS; LEPTIN; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; RADIOIMMUNOASSAY; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956958226     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9573-y     Document Type: Article

References (53)

1. A Redaelli BL Laskin JM Stephens MF Botteman CL Pashos 2004 The clinical and epidemiological burden of chronic lymphocytic leukaemia Eur J Cancer Care 13 279 287 10.1111/j.1365-2354.2004.00489.x 1:STN:280:DC%2BD2c3psFyhuw%3D%3D
2. RS Houlston G Sellick M Yuille E Matutes D Catovsky 2003 Causation of chronic lymphocytic leukemia-insights from familial disease Leuk Res 27 871 876 10.1016/S0145-2126(03)00023-7 12860003
3. L Andritsos H Khoury 2002 Chronic lymphocytic leukemia Curr Treat Opin Oncol 3 225 231 10.1007/s11864-002-0012-5
4. JR Cerhan CA Janney CM Vachon, et al. 2004 Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study Am J Epidemiol 156 527 535 10.1093/aje/kwf082
5. D Barb CJ Williams AK Neuwirth CS Mantzoros 2007 Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am J Clin Nutr 86 s858 s866 18265479
6. SC Larsson A Wolk 2007 Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis Int J Cancer 121 1564 1570 10.1002/ijc.22762 1:CAS:528: DC%2BD2sXhtVSns7zN 17443495
7. SC Larsson A Wolk 2008 Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies Int J Cancer 122 1418 1421 10.1002/ijc.23176 1:CAS:528:DC%2BD1cXit1yht7k%3D 18027857
8. D Barb K Pazaitou-Panayiotou CS Mantzoros 2006 Adiponectin: a link between obesity and cancer Expert Opin Investig Drugs 5 917 931 10.1517/13543784.15.8.917
9. E Petridou CS Mantzoros N Dessypris SK Dikalioti D Trichopoulos 2006 Adiponectin in relation to childhood myeloblastic leukaemia Br J Cancer 94 156 160 10.1038/sj.bjc.6602896 1:CAS:528:DC%2BD28XisVGhug%3D%3D 16404369
10. I Kelesidis T Kelesidis CS Mantzoros 2006 Adiponectin and cancer: a systematic review Br J Cancer 94 1221 1225 10.1038/sj.bjc.6603051 1:CAS:528:DC%2BD28XktVahsbo%3D 16570048
11. BD Bennett GP Solar JQ Yuan J Mathias GR Thomas W Matthews 1996 A role for leptin and its cognate receptor in hematopoiesis Curr Biol 6 1170 1180 10.1016/S0960-9822(02)70684-2 1:CAS:528:DyaK28XlvVSksL8%3D 8805376
12. H Wex E Ponelis T Wex R Dressendorfer U Mittler P Vorwerk 2002 Plasma leptin and leptin receptor expression in childhood acute lymphoblastic leukemia Int J Hematol 76 446 452 10.1007/BF02982810 1:CAS:528:DC%2BD3sXlt1aqtg%3D%3D 12512839
13. M Hino T Nakao T Yamane K Ohta T Takubo N Tatsumi 2000 Leptin receptor and leukemia Leuk Lymphoma 36 457 461 10.3109/10428190009148392 1:CAS:528:DC%2BD3MXovVGr 10784389
14. GE Pamuk M Demir F Harmandar Y Yesil B Turgut O Vural 2006 Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics Exp Oncol 8 241 244
15. T Nakao M Hino T Yamane Y Nishizawa H Morii N Tatsumi 1998 Expression of the leptin receptor in human leukaemic blast cells Br J Haematol 102 740 745 10.1046/j.1365-2141.1998.00843.x 1:CAS:528:DyaK1cXlsleqtb4%3D 9722301
16. T Yamauchi J Kamon H Waki, et al. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 941 946 10.1038/90984 1:CAS:528:DC%2BD3MXlvVOkt7o%3D 11479627
17. Y Wang KS Lam A Xu 2007 Adiponectin as a negative regulator in obesity-related mammary carcinogenesis Cell Res 17 280 282 10.1038/cr.2007.14 1:CAS:528:DC%2BD2sXkt1Chtb8%3D 17404599
18. E Brakenhielm N Veitonmaki R Cao, et al. 2004 Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis Proc Natl Acad Sci 101 2476 2481 10.1073/pnas.0308671100 1:CAS:528:DC%2BD2cXhvVOitro%3D 14983034
19. T Kadowaki T Yamauchi 2005 Adiponectin and adiponectin receptors Endocr Rev 26 439 451 10.1210/er.2005-0005 1:CAS:528:DC%2BD2MXltVWru7c%3D 15897298
20. H Waki T Yamauchi J Kamon, et al. 2005 Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1 Endocrinology 146 790 796 10.1210/en.2004-1096 1:CAS:528:DC%2BD2MXotlWgsQ%3D%3D 15528304
21. H Waki T Yamauchi J Kamon, et al. 2003 Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin J Biol Chem 278 40352 40363 10.1074/jbc.M300365200 1:CAS:528:DC%2BD3sXnvFamt7Y%3D 12878598
22. A Tsuchida T Yamauchi Y Ito, et al. 2004 Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity J Biol Chem 279 30817 30822 10.1074/jbc.M402367200 1:CAS:528:DC%2BD2cXlsFKhsbY%3D 15123605
23. T Yamauchi J Kamon Y Ito, et al. 2003 Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 762 769 10.1038/nature01705 1:CAS:528:DC%2BD3sXksV2itL8%3D 12802337
24. A Korner K Pazaitou-Panayiotou T Kelesidis, et al. 2007 Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies J Clin Endocrinol Metab 92 1041 1048 10.1210/jc.2006-1858 17192291
25. M Dalamaga K Karmaniolas A Nikolaidou, et al. 2008 Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system Eur J Cancer 44 1744 1753 10.1016/j.ejca.2008.04.015 1:CAS:528:DC%2BD1cXpt1Grtbs%3D 18515085
26. M Dalamaga A Nikolaidou K Karmaniolas, et al. 2007 Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study Oncology 73 26 32 10.1159/000120995 18337619
27. M Dalamaga K Karmaniolas A Panagiotou, et al. 2009 Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study Cancer Causes Control 20 193 199 10.1007/s10552-008-9233-7 18814045
28. F Avcu AU Ural MI Yilmaz N Bingol O Nevruz K Caglar 2006 Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases Int J Hematol 83 254 258 10.1532/IJH97.NA0411 16720558
29. GE Pamuk B Turgut M Demir O Vural 2006 Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome J Exp Clin Cancer Res 25 537 541 1:CAS:528:DC%2BD2sXhvFyks7k%3D 17310845
30. BD Cheson JM Bennett M Grever, et al. 1996 National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Blood 87 4990 4997 1:CAS:528:DyaK28XjsFGisb8%3D 8652811
31. NL Harris ES Jaffe J Diebold, et al. 1999 The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997 Ann Oncol 10 1419 1432 10.1023/A:1008375931236 1:STN:280:DC%2BD3c7gvVWntg%3D%3D 10643532
32. JL Binet A Auquier G Dighiero, et al. 1981 A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 48 198 206 10.1002/1097-0142(19810701)48:1<198::AID- CNCR2820480131>3.0.CO;2-V 1:STN:280:DyaL3M3gvFyhtg%3D%3D 7237385
33. DG Oscier E Matutes A Copplestone, et al. 1997 Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12 Br J Hematol 98 934 939 10.1046/j.1365-2141.1997. 3263141.x 1:STN:280:DyaK2svmsFCksA%3D%3D
34. A Wolk G Gridley M Svensson, et al. 2001 A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 12 13 21 10.1023/A:1008995217664 1:STN:280:DC%2BD3M3ksVyluw%3D%3D 11227921
35. T Yokota K Oritani I Takahashi, et al. 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 1723 1732 1:CAS:528:DC%2BD3cXmt1OmtLY%3D 10961870
36. L Cong J Gasser J Zhao B Yang F Li AZ Zhao 2007 Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2 Endocr Relat Cancer 14 713 720 10.1677/ERC-07-0065 1:CAS:528:DC%2BD2sXhsVSitr7O 17914101
37. JD Arditi M Venihaki KP Karalis GP Chrousos 2007 Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer Hormone and metabolic research Hormon- und Stoffwechselforschung 39 9 13 10.1055/s-2007-956518 1:CAS:528: DC%2BD2sXis1Wnsb4%3D
38. Y Wang JB Lam KS Lam, et al. 2006 Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice Cancer Res 66 11462 11470 10.1158/0008-5472.CAN-06-1969 1:CAS:528:DC%2BD28Xht1KnsLrN 17145894
39. L DiMascio C Voermans M Uqoezwa, et al. 2007 Identification of adiponectin as a novel hemopoietic stem cell growth factor J Immunol 178 3511 35120 1:CAS:528:DC%2BD2sXisVGjs70%3D 17339446
40. PO Iversen H Wiig 2005 Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis Clin Cancer Res 11 6793 6799 10.1158/1078-0432.CCR-05-1033 1:CAS:528:DC%2BD2MXhtVKiur3P 16203766
41. T Yokota CS Meka T Kouro, et al. 2003 Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells J Immunol 171 5091 5099 1:CAS:528:DC%2BD3sXoslyjtLk%3D 14607907
42. PC Konturek G Burnat T Rau EG Hahn S Konturek 2008 Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line Dig Dis Sci 53 597 605 10.1007/s10620-007-9922-1 1:CAS:528:DC%2BD1cXisFSqsL8%3D 17763959
43. S Molica G Vitelli G Cutrona, et al. 2008 Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia Int J Hematol 88 374 380 10.1007/s12185-008-0165-5 18818986
44. Bruserud TS Huang N Glenjen BT Gjertsen B Foss 2002 Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts Haematologica 87 584 595 1:CAS:528: DC%2BD38XlsFCit7s%3D 12031914
45. NA Hamed OA Sharaki MM Zeidan 2003 Leptin in acute leukaemias: relationship to interleukin-6 and vascular endothelial growth factor Egypt J Immunol 10 57 66 15719623
46. R Considine M Sinha M Heiman 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 292 295 10.1056/NEJM199602013340503 1:STN:280:DyaK287jtlOnsw%3D%3D 8532024
47. Y Zhang P Scarpace 2006 The role of leptin in leptin resistance and obesity Physiol Behav 88 249 256 10.1016/j.physbeh.2006.05.038 1:CAS:528:DC%2BD28Xmt1Oqtrk%3D 16782141
48. G Boden X Chen M Mozzoli I Ryan 1996 Effect of fasting on serum leptin in normal human subjects J Clin Endocrinol Metab 81 3419 3423 10.1210/jc.81.9.3419 1:CAS:528:DyaK28Xls1Ortbk%3D 8784108
49. J Chan K Heist A DePaoli J Veldhuis 2003 The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men J Clin Invest 11 1409 1421
50. T Gainsford TA Willson D Metcalf, et al. 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells Proc Natl Acad Sci USA 93 14564 14568 10.1073/pnas.93.25.14564 1:CAS:528:DyaK28XnsVKrt74%3D 8962092
51. G Fantuzzi R Faggioni 2000 Leptin in the regulation of immunity, inflammation, and hematopoiesis J Leukoc Biol 68 437 446 1:CAS:528: DC%2BD3cXnsVShtbY%3D 11037963
52. M Konopleva A Mikhail Z Estrov, et al. 1999 Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities Blood 93 1668 1676 1:CAS:528:DyaK1MXhsFeqsr4%3D 10029596
53. HS Berner SP Lyngstadaas A Spahr, et al. 2004 Adiponectin and its receptors are expressed in bone-forming cells Bone 35 842 849 10.1016/j.bone.2004.06.008 1:CAS:528:DC%2BD2cXnvV2rtLo%3D 15454091